MTOR and urinary bladder carcinoma: Puerarin also inhibits bladder cancer cell viability through cell cycle arrest at the G0/G1 phase by a mechanism that involves downregulation of mTOR and p70S6K phosphorylation, without affecting their protein levels (37).